d-cycloserine attenuates scopolamine-induced learning and memory deficits in rats

Abe, 1990, Glycine facilitates induction of long term potentiation in rat hippocampus, Neuroscience Letters, 117, 87, 10.1016/0304-3940(90)90124-R

Becker, 1988, Mechanisms of cholinesterase inhibition in senile dementia of the Alzheimer's type: Clinical, pharmacological, and therapeutic aspects, Drug Development and Research, 12, 163, 10.1002/ddr.430120302

Bliss, 1988, Long-term potentiation of synaptic transmission in the hippocampus: Properties and mechanisms, 3

Buresova, 1986, Differential effects of cholinergic blockade on performance of rats in the water tank navigation task and in a radial water maze, Behavioral Neuroscience, 100, 476, 10.1037/0735-7044.100.4.476

Chaplygina, 1976, Action of Cholinergic drugs in experimental amnesia, Zhurnal Vysshei Nervnoi Deyatel'nosti imeni I. P. Pavlova, 26, 1091

Chatelier, 1990, Tacrine (tetrahydroaminoacridine; THA) and lecithin in senile dementia of the Alzheimer's type: A multicentre trial, British Medical Journal, 300, 495, 10.1136/bmj.300.6723.495

Chessel, 1991, d-Cycloserine, a putative cognitive enhancer, facilitates activation of the N-methyl-d-aspartate receptor-ionophore complex in Alzheimer brain, Brain Research, 565, 345, 10.1016/0006-8993(91)91668-Q

Collingridge, 1990, Excitatory amino acid receptors and synaptic plasticity, Trends in Pharmacological Sciences, 11, 290, 10.1016/0165-6147(90)90011-V

Davis, 1979, Enhancement of memory by physostigmine, New England Journal of Medicine, 301, 946, 10.1056/NEJM197910253011721

Dokla, 1988, Effects of cholinesterase inhibitors on Morris water task behavior following lesions of the nucleus basalis magnocellularis, Behavioral Neurosciences, 102, 861, 10.1037/0735-7044.102.6.861

Fibiger, 1991, Cholinergic mechanisms in learning, memory and dementia: A review of recent evidence, Trends in Neurosciences, 14, 220, 10.1016/0166-2236(91)90117-D

Fitten, 1990, Treatment of Alzheimer's disease with short- and long-term oral THA and lecithin: A double blind study, American Journal of Psychiatry, 147, 239, 10.1176/ajp.147.2.239

Flicker, 1992, Hypersensitivity to scopolamine in the elderly, Psychopharmacology, 107, 437, 10.1007/BF02245172

Forsyth, 1989, Clinical experience with side effects of tacrine hydrochloride in Alzheimer's disease: A pilot study, Age and Ageing, 18, 223, 10.1093/ageing/18.4.223

Greenamyre, 1989, Excitatory amino acids and Alzheimer's disease, Neurobiology of Aging, 10, 593, 10.1016/0197-4580(89)90143-7

Handlemann, 1989, Milacemide, a glycine prodrug, enhances performance of learning tasks in normal and amnestic rodents, Pharmacology, Biochemistry and Behavior, 34, 823, 10.1016/0091-3057(89)90281-5

Haroutunian, 1985, Cholinergic modulation of memory in rats, Psychopharmacology, 87, 266, 10.1007/BF00432705

Herberg, 1990, Effects of d-cycloserine and cycloleucine, ligands for the NMDA-associated strychnine-insensitive glycine site, on brain-stimulation reward and spontaneous locomotion, Pharmacology, Biochemistry and Behavior, 36, 735, 10.1016/0091-3057(90)90069-T

Hollander, 1986, Cholinergic approaches to the treatment of Alzheimer's disease, Brain Medical Bulletin, 47, 40

Hood, 1989, d-Cycloserine: A ligand for the N-methyl-d-aspartate coupled glycine receptor has partial agonist characteristics, Neuroscience Letters, 98, 91, 10.1016/0304-3940(89)90379-0

Izquierdo, 1991, Role of NMDA receptors in memory, Trends in Pharmacological Sciences, 12, 128, 10.1016/0165-6147(91)90527-Y

Johnson, 1987, Glycine potentiates the NMDA response in cultured mouse brain neurons, Nature, 325, 529, 10.1038/325529a0

Johnston, 1979, Evidence for a cholinergic projection to neocortex from neurons in the basal forebrain, 76, 5392

Jones, 1991, Effects of NMDA modulation in scopolamine dementia, Annals of the New York Academy of Sciences, 640, 241, 10.1111/j.1749-6632.1991.tb00226.x

Jotkowitz, 1983, Lack of clinical efficacy of chronic oral physostigmine in Alzheimer's disease, Annals of Neurology, 14, 690, 10.1002/ana.410140616

Madison, 1991, Mechanisms underlying long-term potentiation of synaptic transmissions, 14, 379

Mandel, 1989, Continuous physostigmine infusion in rats with excitotoxic lesions of the nucleus basalis magnocellularis: Effects on performance in the water maze task and cortical cholinergic markers, Journal of Pharmacology and Experimental Therapeutics, 251, 612

Mandel, 1989, Enhanced detection of nucleus basalis magnocellularis lesion-induced spatial learning deficit in rats by modification of training regimen, Behavioural Brain Research, 31, 221, 10.1016/0166-4328(89)90004-1

Mohs, 1985, Oral physostigmine treatment of patients with Alzheimer's disease, American Journal of Psychiatry, 142, 28, 10.1176/ajp.142.1.28

Monahan, 1989, n-Cycloserine a positive modulator of the Nmethyl-d-aspartate receptor, enhances performance of learning tasks in rats, Pharmacology, Biochemistry and Behavior, 34, 649, 10.1016/0091-3057(89)90571-6

Moriyoshi, 1991, Molecular cloning and characterization of the rat NMDA receptor, Nature, 354, 31, 10.1038/354031a0

Morris, 1982, Place navigation impaired in rats with hippocampal lesions, Nature, 297, 681, 10.1038/297681a0

Morris, 1986, Selective impairment of learning and blockade of long-term potentiation by an N-methyl-d-aspartate receptor antagonist, AP5, Nature, 319, 774, 10.1038/319774a0

Nishimura, 1990, N-methyl-d-aspartate-evoked release of acetylcholine from the medial septum/diagonal and of rat brain, Neuroscience Letters, 115, 259, 10.1016/0304-3940(90)90465-L

Okaichi, 1982, Scopolamine impairs performance of a place and cue task in rats, Behavioral and Neural Biology, 35, 319, 10.1016/S0163-1047(82)90761-0

Oliver, 1990, Glycine site associated with the NMDA receptor modulates long-term potentiation, Synapse, 5, 265, 10.1002/syn.890050403

Olton, 1987, Dementia: Animal models of cognitive impairments produced by degeneration of the basal forebrain cholinergic systems, 941

Palmer, 1990, Is the neuronal basis of Alzheimer's disease cholinergic or glutamatergic?, FASEB Journal, 4, 2745, 10.1096/fasebj.4.10.2165009

Palmer, 1986, Excitatory amino acid-releasing and cholinergic neurons in Alzheimer's disease, Neuroscience Letters, 66, 199, 10.1016/0304-3940(86)90190-4

Perry, 1986, The cholinergic hypothesis—Ten years on, British Medical Bulletin, 42, 63, 10.1093/oxfordjournals.bmb.a072100

Proctor, 1989, Loss of glycine radioligand binding to the N-methyl-d-aspartate-phencyclidine receptor complex in patients with Alzheimer's disease, Neuroscience Letters, 101, 62, 10.1016/0304-3940(89)90441-2

Proctor, 1989, Reduced glycine stimulation of [3H]MK-801 binding in Alzheimer's disease, Journal of Neuroscience, 53, 698

Raiteri, 1990, Glycine enhances [3H]noradrenaline release from slices of rat hippocampus, Neuroscience Letters, 116, 352, 10.1016/0304-3940(90)90100-N

Ransom, 1989, Glycine modulation of NMDA-evoked release of [3H]acetylcholine and [3H]dopamine from rat striatal slices, Neuroscience Letters, 96, 323, 10.1016/0304-3940(89)90399-6

Richter-Levin, 1989, Spatial performance is severely impaired in rats with combined reduction of serotonergic and cholinergic transmission, Brain Research, 477, 404, 10.1016/0006-8993(89)91437-6

Rosser, 1986, Non-cholinergic neurotransmitter abnormalities in Alzheimer's disease, British Medical Bulletin, 42, 70, 10.1093/oxfordjournals.bmb.a072101

Rupniak, 1992, Failure of d-cycloserine to reverse cognitive disruption induced by scopolamine or phencyclidine in primates, Life Sciences, 50, 1959, 10.1016/0024-3205(92)90525-T

Sahakian, 1988, Cholinergic drugs and human cognitive performance, 394

Sahgal, 1990, Memory following cholinergic (NBM) and noradrenergic (DNAB) lesions made singly or in combination: Potentiation of disruption by scopolamine, Pharmacology Biochemistry and Behavior, 37, 597, 10.1016/0091-3057(90)90533-N

Salamone, 1984, Impairment in the T-maze reinforced alternation performance following nucleus basalis magnocellularis lesions in the rat, Behavioral Brain Research, 13, 63, 10.1016/0166-4328(84)90030-5

Sarter, 1992, Behavioral screening for cognition enhancers: From indiscriminate to valid testing: Part I, Psychopharmacology, 107, 144, 10.1007/BF02245132

Scatton, 1982, N-methyl-d-aspartate receptor mediates striatal [3H]acetylcholine evoked release by excitatory amino acids, Nature, 297, 422, 10.1038/297422a0

Singh, 1990, Modulation of seizure susceptibility in the mouse byt he strychnine-insensitive glycine recognition site of the NMDA receptor/ion channel complex, British Journal of Pharmacology, 99, 285, 10.1111/j.1476-5381.1990.tb14695.x

Smith, 1988, Animal models of Alzheimer's disease: Experimental cholinergic deneravation, Brain Research Reviews, 3, 103, 10.1016/0165-0173(88)90016-1

Sweeny, 1988, A long-acting cholinesterase inhibitor reverses spatial memory deficits in mice, Pharmacology, Biochemistry and Behavior, 31, 141, 10.1016/0091-3057(88)90325-5

Sweeny, 1990, Effects of different doses of galanthamine, a long-acting acetylcholinesterase inhibitor, on memory in mice, Psychopharmacology, 102, 191, 10.1007/BF02245921

Taylor, 1988, Glycine-evoked release of [3H]acetylcholine from rat striatal slices is independent of NMDA receptor, Naunyn-Schmiedeburg's Archives of Pharmacology, 337, 552

Thal, 1983, Memory enhancement with oral physostigmine in Alzheimer's disease, New England Journal of Medicine, 308, 720, 10.1056/NEJM198303243081212

Thomson, 1989, Glycine enhances NMDA-receptor mediated synaptic potentials in neocortical slices, Nature, 338, 422, 10.1038/338422a0

Westra, 1986, Pharmacokinetics of galanthamine (a long-acting anticholinesterase drug) in anesthetized patients, British Journal of Anaesthesiology, 58, 1303, 10.1093/bja/58.11.1303

Wishaw, 1985, Cholinergic receptor blockage in the rats impairs locale but not taxon strategies for place in navigation in a swimming pool, Behavioral Neuroscience, 5, 976

Wishaw, 1989, Immediate and long-lasting effects of MK-801 on motor activity, spatial navigation in a swimming pool and EEG in the rat, Psychopharmacology, 98, 500, 10.1007/BF00441949